메뉴 건너뛰기




Volumn 86, Issue 8, 2012, Pages 4328-4339

Discovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROTEOME; THROMBOSPONDIN; VIRUS ANTIGEN; VIRUS PROTEIN; VIRUS VACCINE;

EID: 84861388449     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05194-11     Document Type: Article
Times cited : (41)

References (83)
  • 1
    • 77949568869 scopus 로고    scopus 로고
    • Human antibodies to herpes simplex virus type 1 glycoprotein C are neutralizing and target the heparan sulfate-binding domain
    • Adamiak B, et al. 2010. Human antibodies to herpes simplex virus type 1 glycoprotein C are neutralizing and target the heparan sulfate-binding domain. Virology 400:197-206.
    • (2010) Virology , vol.400 , pp. 197-206
    • Adamiak, B.1
  • 2
    • 0034921526 scopus 로고    scopus 로고
    • Sorting out the new HSV type specific antibody tests
    • Ashley RL. 2001. Sorting out the new HSV type specific antibody tests. Sex. Transm. Infect. 77:232-237.
    • (2001) Sex. Transm. Infect. , vol.77 , pp. 232-237
    • Ashley, R.L.1
  • 3
    • 0032923917 scopus 로고    scopus 로고
    • Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection
    • Ashley RL, Eagleton M, Pfeiffer N. 1999. Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection. J. Clin. Microbiol. 37:1632-1633.
    • (1999) J. Clin. Microbiol. , vol.37 , pp. 1632-1633
    • Ashley, R.L.1    Eagleton, M.2    Pfeiffer, N.3
  • 4
    • 0023473319 scopus 로고
    • Use of densitometric analysis for interpreting HSV serologies based on Western blot
    • Ashley RL, Militoni J. 1987. Use of densitometric analysis for interpreting HSV serologies based on Western blot. J. Virol. Methods 18:159-168.
    • (1987) J. Virol. Methods , vol.18 , pp. 159-168
    • Ashley, R.L.1    Militoni, J.2
  • 5
    • 0023837735 scopus 로고
    • Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera
    • Ashley RL, Militoni J, Lee F, Nahmias A, Corey L. 1988. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J. Clin. Microbiol. 26:662-667.
    • (1988) J. Clin. Microbiol. , vol.26 , pp. 662-667
    • Ashley, R.L.1    Militoni, J.2    Lee, F.3    Nahmias, A.4    Corey, L.5
  • 6
    • 0037383018 scopus 로고    scopus 로고
    • Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2
    • Ashley-Morrow R, Krantz E, Wald A. 2003. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Sex. Transm. Dis. 30:310-314.
    • (2003) Sex. Transm. Dis. , vol.30 , pp. 310-314
    • Ashley-Morrow, R.1    Krantz, E.2    Wald, A.3
  • 7
    • 0034948896 scopus 로고    scopus 로고
    • A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes
    • Baldi P, Long AD. 2001. A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics 17:509-519.
    • (2001) Bioinformatics , vol.17 , pp. 509-519
    • Baldi, P.1    Long, A.D.2
  • 8
    • 0024593560 scopus 로고
    • A major neutralizing domain maps within the carboxyl-terminal half of the cleaved cytomegalovirus B glycoprotein
    • Banks T, et al. 1989. A major neutralizing domain maps within the carboxyl-terminal half of the cleaved cytomegalovirus B glycoprotein. J. Gen. Virol. 70(Pt 4):979-985.
    • (1989) J. Gen. Virol. , vol.70 , Issue.PART 4 , pp. 979-985
    • Banks, T.1
  • 9
    • 78650370215 scopus 로고    scopus 로고
    • Herpes simplex virus type 2 seropositivity and relationship status among U S. adults age 20 to 49 a population-based analysis
    • Bauer GR, Khobzi N, Coleman TA. 2010. Herpes simplex virus type 2 seropositivity and relationship status among U.S. adults age 20 to 49: a population-based analysis. BMC Infect. Dis. 10:359.
    • (2010) BMC Infect. Dis. , vol.10 , pp. 359
    • Bauer, G.R.1    Khobzi, N.2    Coleman, T.A.3
  • 10
    • 0001677717 scopus 로고
    • Controlling the false discovery rate: a practical and powerful approach to multiple testing
    • Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57:289-300.
    • (1995) J. R. Stat. Soc. B , vol.57 , pp. 289-300
    • Benjamini, Y.1    Hochberg, Y.2
  • 11
    • 0042890384 scopus 로고    scopus 로고
    • Identification of novel immunodominant CD4+Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity
    • BenMohamed L, et al. 2003. Identification of novel immunodominant CD4+Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity. J. Virol. 77:9463-9473.
    • (2003) J. Virol. , vol.77 , pp. 9463-9473
    • BenMohamed, L.1
  • 12
    • 0030792120 scopus 로고    scopus 로고
    • The acquisition of herpes simplex virus during pregnancy
    • Brown ZA, et al. 1997. The acquisition of herpes simplex virus during pregnancy. N. Engl. J. Med. 337:509-515.
    • (1997) N. Engl. J. Med. , vol.337 , pp. 509-515
    • Brown, Z.A.1
  • 13
    • 0037425558 scopus 로고    scopus 로고
    • Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant
    • Brown ZA, et al. 2003. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 289:203-209.
    • (2003) JAMA , vol.289 , pp. 203-209
    • Brown, Z.A.1
  • 14
    • 0023387940 scopus 로고
    • Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection
    • Cantin EM, et al. 1987. Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection. Proc. Natl. Acad. Sci. U.S.A. 84:5908-5912.
    • (1987) Proc. Natl. Acad. Sci. U.S.A. , vol.84 , pp. 5908-5912
    • Cantin, E.M.1
  • 15
    • 0029859491 scopus 로고    scopus 로고
    • T cell recognition and cytokine production elicited by common and type-specific glycoproteins of herpes simplex virus type 1 and type 2
    • Carmack MA, et al. 1996. T cell recognition and cytokine production elicited by common and type-specific glycoproteins of herpes simplex virus type 1 and type 2. J. Infect. Dis. 174:899-906.
    • (1996) J. Infect. Dis. , vol.174 , pp. 899-906
    • Carmack, M.A.1
  • 16
    • 77951244078 scopus 로고    scopus 로고
    • Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years-United States 2005-2008
    • CDC
    • CDC. 2010. Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years-United States, 2005-2008. MMWR Morb. Mortal. Wkly. Rep. 59:456-459.
    • (2010) MMWR Morb. Mortal. Wkly. Rep. , vol.59 , pp. 456-459
  • 17
    • 56449115358 scopus 로고    scopus 로고
    • Asymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein B
    • Chentoufi AA, et al. 2008. Asymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein B. J. Virol. 82:11792-11802.
    • (2008) J. Virol. , vol.82 , pp. 11792-11802
    • Chentoufi, A.A.1
  • 18
    • 40449086460 scopus 로고    scopus 로고
    • HLA- A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D
    • Chentoufi AA, et al. 2008. HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D. J. Immunol. 180:426-437.
    • (2008) J. Immunol. , vol.180 , pp. 426-437
    • Chentoufi, A.A.1
  • 19
    • 0033612702 scopus 로고    scopus 로고
    • Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials Chiron HSV Vaccine Study Group
    • Corey L, et al. 1999. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA 282:331-340.
    • (1999) JAMA , vol.282 , pp. 331-340
    • Corey, L.1
  • 20
    • 77951078453 scopus 로고    scopus 로고
    • A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray
    • Crompton PD, et al. 2010. A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc. Natl. Acad. Sci. U.S.A. 107:6958-6963.
    • (2010) Proc. Natl. Acad. Sci. U.S.A. , vol.107 , pp. 6958-6963
    • Crompton, P.D.1
  • 21
    • 0030853022 scopus 로고    scopus 로고
    • Rapid detection and typing of herpes simplex virus DNA in clinical specimens by the Hybrid Capture II signal amplification probe test
    • Cullen AP, Long CD, Lorincz AT. 1997. Rapid detection and typing of herpes simplex virus DNA in clinical specimens by the Hybrid Capture II signal amplification probe test. J. Clin. Microbiol. 35:2275-2278.
    • (1997) J. Clin. Microbiol. , vol.35 , pp. 2275-2278
    • Cullen, A.P.1    Long, C.D.2    Lorincz, A.T.3
  • 22
    • 0027514853 scopus 로고
    • A cosmid-based system for constructing mutants of herpes simplex virus type 1
    • Cunningham C, Davison AJ. 1993. A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology 197:116-124.
    • (1993) Virology , vol.197 , pp. 116-124
    • Cunningham, C.1    Davison, A.J.2
  • 24
    • 20044369888 scopus 로고    scopus 로고
    • Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery
    • Davies DH, et al. 2005. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc. Natl. Acad. Sci. U.S.A. 102:547-552.
    • (2005) Proc. Natl. Acad. Sci. U.S.A. , vol.102 , pp. 547-552
    • Davies, D.H.1
  • 25
    • 0034659112 scopus 로고    scopus 로고
    • Dual role of B cells in mediating innate and acquired immunity to herpes simplex virus infections
    • Deshpande SP, Kumaraguru U, Rouse BT. 2000. Dual role of B cells in mediating innate and acquired immunity to herpes simplex virus infections. Cell. Immunol. 202:79-87.
    • (2000) Cell. Immunol. , vol.202 , pp. 79-87
    • Deshpande, S.P.1    Kumaraguru, U.2    Rouse, B.T.3
  • 27
    • 0026765465 scopus 로고
    • Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C
    • Dolter KE, Goins WF, Levine M, Glorioso JC. 1992. Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C. J. Virol. 66:4864-4873.
    • (1992) J. Virol. , vol.66 , pp. 4864-4873
    • Dolter, K.E.1    Goins, W.F.2    Levine, M.3    Glorioso, J.C.4
  • 28
    • 0025789927 scopus 로고
    • Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity
    • Dubin G, Socolof E, Frank I, Friedman HM. 1991. Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity. J. Virol. 65:7046-7050.
    • (1991) J. Virol. , vol.65 , pp. 7046-7050
    • Dubin, G.1    Socolof, E.2    Frank, I.3    Friedman, H.M.4
  • 29
    • 0012572299 scopus 로고    scopus 로고
    • A variancestabilizing transformation for gene-expression microarray data
    • Durbin BP, Hardin JS, Hawkins DM, Rocke DM. 2002. A variancestabilizing transformation for gene-expression microarray data. Bioinformatics 18(Suppl 1):S105-S110.
    • (2002) Bioinformatics , vol.18 , Issue.SUPPL. 1
    • Durbin, B.P.1    Hardin, J.S.2    Hawkins, D.M.3    Rocke, D.M.4
  • 30
    • 0022337655 scopus 로고
    • Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge
    • Eisenberg RJ, et al. 1985. Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge. J. Virol. 56:1014-1017.
    • (1985) J. Virol. , vol.56 , pp. 1014-1017
    • Eisenberg, R.J.1
  • 31
    • 69449101951 scopus 로고    scopus 로고
    • A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens
    • Felgner PL, et al. 2009. A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens. Proc. Natl. Acad. Sci. U.S.A. 106:13499-13504.
    • (2009) Proc. Natl. Acad. Sci. U.S.A. , vol.106 , pp. 13499-13504
    • Felgner, P.L.1
  • 32
    • 0030744945 scopus 로고    scopus 로고
    • Herpes simplex virus type 2 in the United States 1976 to 1994
    • Fleming DT, et al. 1997. Herpes simplex virus type 2 in the United States, 1976 to 1994. N. Engl. J. Med. 337:1105-1111.
    • (1997) N. Engl. J. Med. , vol.337 , pp. 1105-1111
    • Fleming, D.T.1
  • 33
    • 29144444035 scopus 로고    scopus 로고
    • Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies
    • Freeman EE, et al. 2006. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20:73-83.
    • (2006) AIDS , vol.20 , pp. 73-83
    • Freeman, E.E.1
  • 34
    • 0033021239 scopus 로고    scopus 로고
    • Identification of type-specific domains within glycoprotein G of herpes simplex virus type 2 (HSV-2) recognized by themajority of patients infected with HSV-2, but not by those infected with HSV-1
    • Grabowska A, et al. 1999. Identification of type-specific domains within glycoprotein G of herpes simplex virus type 2 (HSV-2) recognized by themajority of patients infected with HSV-2, but not by those infected with HSV-1. J. Gen. Virol. 80(Pt 7):1789-1798.
    • (1999) J. Gen. Virol. , vol.80 , Issue.PART 7 , pp. 1789-1798
    • Grabowska, A.1
  • 35
    • 0020326053 scopus 로고
    • Mechanism of antibody-mediated protection against herpes simplex virus infection in athymic nude mice: requirement of Fc portion of antibody
    • Hayashida I, et al. 1982. Mechanism of antibody-mediated protection against herpes simplex virus infection in athymic nude mice: requirement of Fc portion of antibody. Microbiol. Immunol. 26:497-509.
    • (1982) Microbiol. Immunol. , vol.26 , pp. 497-509
    • Hayashida, I.1
  • 36
    • 84355165249 scopus 로고    scopus 로고
    • Measurement of antibody responses to modified vaccinia virus Ankara (MVA) and Dryvax® using proteome microarrays and development of recombinant protein ELISAs
    • Hermanson G, et al. 2012. Measurement of antibody responses to modified vaccinia virus Ankara (MVA) and Dryvax® using proteome microarrays and development of recombinant protein ELISAs. Vaccine 30:614-625.
    • (2012) Vaccine , vol.30 , pp. 614-625
    • Hermanson, G.1
  • 37
    • 33646734890 scopus 로고    scopus 로고
    • Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes
    • Hosken N, et al. 2006. Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes. J. Virol. 80:5509-5515.
    • (2006) J. Virol. , vol.80 , pp. 5509-5515
    • Hosken, N.1
  • 38
    • 11244346557 scopus 로고    scopus 로고
    • Variance stabilization applied to microarray data calibration and to the quantification of differential expression
    • Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M. 2002. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18(Suppl 1): S96-S104.
    • (2002) Bioinformatics , vol.18 , Issue.SUPPL. 1
    • Huber, W.1    von Heydebreck, A.2    Sultmann, H.3    Poustka, A.4    Vingron, M.5
  • 39
    • 0028846789 scopus 로고
    • Effects of the passive transfer of anti-gB antibodies in a rabbit model of HSV-1-induced keratitis
    • Incorvaia C, et al. 1995. Effects of the passive transfer of anti-gB antibodies in a rabbit model of HSV-1-induced keratitis. Ophthalmologica 209: 340-345.
    • (1995) Ophthalmologica , vol.209 , pp. 340-345
    • Incorvaia, C.1
  • 40
    • 47049112234 scopus 로고    scopus 로고
    • An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling
    • Jing L, et al. 2008. An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling. J. Virol. 82:7120-7134.
    • (2008) J. Virol. , vol.82 , pp. 7120-7134
    • Jing, L.1
  • 41
    • 0029548268 scopus 로고
    • Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays
    • Kakkanas A, et al. 1995. Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays. Intervirology 38:346-351.
    • (1995) Intervirology , vol.38 , pp. 346-351
    • Kakkanas, A.1
  • 42
    • 0027991985 scopus 로고
    • Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions
    • Koelle DM, Abbo H, Peck A, Ziegweid K, Corey L. 1994. Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions. J. Infect. Dis. 169:956-961.
    • (1994) J. Infect. Dis. , vol.169 , pp. 956-961
    • Koelle, D.M.1    Abbo, H.2    Peck, A.3    Ziegweid, K.4    Corey, L.5
  • 43
    • 0035869533 scopus 로고    scopus 로고
    • CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells
    • Koelle DM, et al. 2001. CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells. J. Immunol. 166:4049-4058.
    • (2001) J. Immunol. , vol.166 , pp. 4049-4058
    • Koelle, D.M.1
  • 44
    • 0037237569 scopus 로고    scopus 로고
    • Recent progress in herpes simplex virus immunobiology and vaccine research
    • Koelle DM, Corey L. 2003. Recent progress in herpes simplex virus immunobiology and vaccine research. Clin. Microbiol. Rev. 16:96-113.
    • (2003) Clin. Microbiol. Rev. , vol.16 , pp. 96-113
    • Koelle, D.M.1    Corey, L.2
  • 45
    • 0028301850 scopus 로고
    • Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions
    • Koelle DM, et al. 1994. Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions. J. Virol. 68:2803-2810.
    • (1994) J. Virol. , vol.68 , pp. 2803-2810
    • Koelle, D.M.1
  • 46
    • 0242300084 scopus 로고    scopus 로고
    • Immunodominance among herpes simplex virusspecific CD8 T cells expressing a tissue-specific homing receptor
    • Koelle DM, et al. 2003. Immunodominance among herpes simplex virusspecific CD8 T cells expressing a tissue-specific homing receptor. Proc. Natl. Acad. Sci. U.S.A. 100:12899-12904.
    • (2003) Proc. Natl. Acad. Sci. U.S.A. , vol.100 , pp. 12899-12904
    • Koelle, D.M.1
  • 47
    • 0032703698 scopus 로고    scopus 로고
    • Adhesion defects of antibody-mediated target cell binding of neonatal natural killer cells
    • Kohl S, Sigouroudinia M, Engleman EG. 1999. Adhesion defects of antibody-mediated target cell binding of neonatal natural killer cells. Pediatr. Res. 46:755-759.
    • (1999) Pediatr. Res. , vol.46 , pp. 755-759
    • Kohl, S.1    Sigouroudinia, M.2    Engleman, E.G.3
  • 48
    • 0027223717 scopus 로고
    • Role of NK cells in immunomodulator-mediated resistance to herpesvirus infection
    • Kunder SC, Wu L, Morahan PS. 1993. Role of NK cells in immunomodulator-mediated resistance to herpesvirus infection. Antiviral Res. 21:103-118.
    • (1993) Antiviral Res , vol.21 , pp. 103-118
    • Kunder, S.C.1    Wu, L.2    Morahan, P.S.3
  • 49
    • 77957071675 scopus 로고    scopus 로고
    • Dynamic antibody responses to the Mycobacterium tuberculosis proteome
    • Kunnath-Velayudhan S, et al. 2010. Dynamic antibody responses to the Mycobacterium tuberculosis proteome. Proc. Natl. Acad. Sci. U.S.A. 107:14703-14708.
    • (2010) Proc. Natl. Acad. Sci. U.S.A. , vol.107 , pp. 14703-14708
    • Kunnath-Velayudhan, S.1
  • 50
    • 0029000226 scopus 로고
    • A recombinant glycoprotein vaccine for herpes simplex virus type 2 safety and immunogenicity [corrected]
    • Langenberg AG, et al. 1995. A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity [corrected]. Ann. Intern. Med. 122:889-898.
    • (1995) Ann. Intern. Med. , vol.122 , pp. 889-898
    • Langenberg, A.G.1
  • 51
    • 0021191322 scopus 로고
    • DNA sequence analysis of the typecommon glycoprotein-D genes of herpes simplex virus types 1 and 2
    • Lasky LA, Dowbenko DJ. 1984. DNA sequence analysis of the typecommon glycoprotein-D genes of herpes simplex virus types 1 and 2. DNA 3:23-29.
    • (1984) DNA , vol.3 , pp. 23-29
    • Lasky, L.A.1    Dowbenko, D.J.2
  • 52
    • 79958002548 scopus 로고    scopus 로고
    • Identification of potential serodiagnostic and subunit vaccine antigens by antibody profiling of toxoplasmosis cases in Turkey
    • Liang L, et al. 2011. Identification of potential serodiagnostic and subunit vaccine antigens by antibody profiling of toxoplasmosis cases in Turkey. Mol. Cell. Proteomics 10:M110.00691.
    • (2011) Mol. Cell. Proteomics , vol.10
    • Liang, L.1
  • 53
    • 0035827588 scopus 로고    scopus 로고
    • Improved statistical inference from DNA microarray data using analysis of variance and a Bayesian statistical framework Analysis of global gene expression in Escherichia coli K12
    • Long AD, et al. 2001. Improved statistical inference from DNA microarray data using analysis of variance and a Bayesian statistical framework. Analysis of global gene expression in Escherichia coli K12. J. Biol. Chem. 276:19937-19944.
    • (2001) J. Biol. Chem. , vol.276 , pp. 19937-19944
    • Long, A.D.1
  • 54
    • 77955514666 scopus 로고    scopus 로고
    • High-throughput profiling of the humoral immune responses against thirteen human papillomavirus types by proteome microarrays
    • Luevano M, et al. 2010. High-throughput profiling of the humoral immune responses against thirteen human papillomavirus types by proteome microarrays. Virology 405:31-40.
    • (2010) Virology , vol.405 , pp. 31-40
    • Luevano, M.1
  • 55
    • 0025021453 scopus 로고
    • Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B constitutively expressed in human cells with a BK virus episomal vector
    • Manservigi R, et al. 1990. Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B constitutively expressed in human cells with a BK virus episomal vector. J. Virol. 64:431-436.
    • (1990) J. Virol. , vol.64 , pp. 431-436
    • Manservigi, R.1
  • 56
    • 0021247875 scopus 로고
    • Characterization of the 92 000-dalton glycoprotein induced by herpes simplex virus type 2
    • Marsden HS, Buckmaster A, Palfreyman JW, Hope RG, Minson AC. 1984. Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2. J. Virol. 50:547-554.
    • (1984) J. Virol. , vol.50 , pp. 547-554
    • Marsden, H.S.1    Buckmaster, A.2    Palfreyman, J.W.3    Hope, R.G.4    Minson, A.C.5
  • 57
    • 0029909383 scopus 로고    scopus 로고
    • Immunization with DNA vaccines encoding glycoproteinDor glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease
    • McClements WL, Armstrong ME, Keys RD, Liu MA. 1996. Immunization with DNA vaccines encoding glycoproteinDor glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc. Natl. Acad. Sci. U.S.A. 93:11414-11420.
    • (1996) Proc. Natl. Acad. Sci. U.S.A. , vol.93 , pp. 11414-11420
    • McClements, W.L.1    Armstrong, M.E.2    Keys, R.D.3    Liu, M.A.4
  • 58
    • 0025285805 scopus 로고
    • Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2
    • McDermott MR, Brais LJ, Evelegh MJ. 1990. Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2. J. Gen. Virol. 71(Pt 7):1497-1504.
    • (1990) J. Gen. Virol. , vol.71 , Issue.PART 7 , pp. 1497-1504
    • McDermott, M.R.1    Brais, L.J.2    Evelegh, M.J.3
  • 59
    • 0024560311 scopus 로고
    • Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B
    • McDermott MR, Graham FL, Hanke T, Johnson DC. 1989. Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B. Virology 169: 244-247.
    • (1989) Virology , vol.169 , pp. 244-247
    • McDermott, M.R.1    Graham, F.L.2    Hanke, T.3    Johnson, D.C.4
  • 60
    • 0023899276 scopus 로고
    • The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1
    • McGeoch DJ, et al. 1988. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol. 69(Pt 7):1531-1574.
    • (1988) J. Gen. Virol. , vol.69 , Issue.PART 7 , pp. 1531-1574
    • McGeoch, D.J.1
  • 61
    • 0023205074 scopus 로고
    • DNA sequence and genetic content of the HindIII l region in the short unique component of the herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G, and evolutionary comparisons
    • McGeoch DJ, Moss HW, McNab D, Frame MC. 1987. DNA sequence and genetic content of the HindIII l region in the short unique component of the herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G, and evolutionary comparisons. J. Gen. Virol. 68(Pt 1):19-38.
    • (1987) J. Gen. Virol. , vol.68 , Issue.PART 1 , pp. 19-38
    • McGeoch, D.J.1    Moss, H.W.2    McNab, D.3    Frame, M.C.4
  • 62
    • 0021922525 scopus 로고
    • IgG- mediated viral clearance in experimental infection with herpes simplex virus type 1 role for neutralization and Fcdependent functions but notC= cytolysis and C5 chemotaxis
    • McKendall RR. 1985. IgG-mediated viral clearance in experimental infection with herpes simplex virus type 1: role for neutralization and Fcdependent functions but notC= cytolysis and C5 chemotaxis. J. Infect. Dis. 151:464-470.
    • (1985) J. Infect. Dis. , vol.151 , pp. 464-470
    • McKendall, R.R.1
  • 63
    • 0023931237 scopus 로고
    • The immunoglobulin response to individual HSV-1 viral polypeptides: kinetics of the response during primary and secondary experimental infection with herpes simplex virus
    • McKendall RR, Pettit M, Woo W. 1988. The immunoglobulin response to individual HSV-1 viral polypeptides: kinetics of the response during primary and secondary experimental infection with herpes simplex virus. J. Med. Microbiol. 25:59-66.
    • (1988) J. Med. Microbiol. , vol.25 , pp. 59-66
    • McKendall, R.R.1    Pettit, M.2    Woo, W.3
  • 65
    • 0023883599 scopus 로고
    • Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study
    • Mertz GJ, et al. 1988. Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. J. Infect. Dis. 157:1169-1177.
    • (1988) J. Infect. Dis. , vol.157 , pp. 1169-1177
    • Mertz, G.J.1
  • 66
    • 0031985087 scopus 로고    scopus 로고
    • Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes
    • Mikloska Z, Cunningham AL. 1998. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes. J. Gen. Virol. 79(Pt 2):353-361.
    • (1998) J. Gen. Virol. , vol.79 , Issue.PART 2 , pp. 353-361
    • Mikloska, Z.1    Cunningham, A.L.2
  • 67
    • 0030063162 scopus 로고    scopus 로고
    • Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma
    • Mikloska Z, Kesson AM, Penfold ME, Cunningham AL. 1996. Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma. J. Infect. Dis. 173:7-17.
    • (1996) J. Infect. Dis. , vol.173 , pp. 7-17
    • Mikloska, Z.1    Kesson, A.M.2    Penfold, M.E.3    Cunningham, A.L.4
  • 68
    • 0035155851 scopus 로고    scopus 로고
    • Vaccine-induced serum immunoglobulin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells
    • Morrison LA, Zhu L, Thebeau LG. 2001. Vaccine-induced serum immunoglobulin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells. J. Virol. 75:1195-1204.
    • (2001) J. Virol. , vol.75 , pp. 1195-1204
    • Morrison, L.A.1    Zhu, L.2    Thebeau, L.G.3
  • 69
    • 34249813713 scopus 로고    scopus 로고
    • Vaccinia virus-specific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses
    • Moutaftsi M, et al. 2007. Vaccinia virus-specific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses. J. Immunol. 178:6814-6820.
    • (2007) J. Immunol. , vol.178 , pp. 6814-6820
    • Moutaftsi, M.1
  • 70
    • 77950865479 scopus 로고    scopus 로고
    • Uncovering the interplay between CD8 CD4 and antibody responses to complex pathogens
    • Moutaftsi M, et al. 2010. Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens. Future Microbiol. 5:221-239.
    • (2010) Future Microbiol , vol.5 , pp. 221-239
    • Moutaftsi, M.1
  • 71
    • 0037446668 scopus 로고    scopus 로고
    • T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?
    • Posavad CM, et al. 2003. T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity? J. Immunol. 170:4380-4388.
    • (2003) J. Immunol. , vol.170 , pp. 4380-4388
    • Posavad, C.M.1
  • 72
    • 0023737057 scopus 로고
    • Passive transfer of anti-HSV-1 IgG protects against stromal keratitis in mice
    • Raizman MB, Foster CS. 1988. Passive transfer of anti-HSV-1 IgG protects against stromal keratitis in mice. Curr. Eye Res. 7:823-829.
    • (1988) Curr. Eye Res. , vol.7 , pp. 823-829
    • Raizman, M.B.1    Foster, C.S.2
  • 73
    • 0023937721 scopus 로고
    • Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination
    • Rooney JF, Wohlenberg C, Cremer KJ, Moss B, Notkins AL. 1988. Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination. J. Virol. 62:1530-1534.
    • (1988) J. Virol. , vol.62 , pp. 1530-1534
    • Rooney, J.F.1    Wohlenberg, C.2    Cremer, K.J.3    Moss, B.4    Notkins, A.L.5
  • 74
    • 77952669199 scopus 로고    scopus 로고
    • The glycoproteins C and G are equivalent target antigens for the determination of herpes simplex virus type 1-specific antibodies
    • Scheper T, et al. 2010. The glycoproteins C and G are equivalent target antigens for the determination of herpes simplex virus type 1-specific antibodies. J. Virol. Methods 166:42-47.
    • (2010) J. Virol. Methods , vol.166 , pp. 42-47
    • Scheper, T.1
  • 75
    • 9344251685 scopus 로고    scopus 로고
    • National seroprevalence and trends in herpes simplex virus type 1 in the United States 1976-1994
    • Schillinger JA, et al. 2004. National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994. Sex Transm. Dis. 31:753-760.
    • (2004) Sex Transm. Dis. , vol.31 , pp. 753-760
    • Schillinger, J.A.1
  • 76
    • 4344573865 scopus 로고    scopus 로고
    • Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines
    • Stanberry LR. 2004 Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines. Herpes 11(Suppl 3):161A-169A.
    • (2004) Herpes , vol.11 , Issue.SUPPL. 3
    • Stanberry, L.R.1
  • 77
    • 0037153024 scopus 로고    scopus 로고
    • Glycoprotein-D-adjuvant vaccine to prevent genital herpes
    • Stanberry LR, et al. 2002. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N. Engl. J. Med. 347:1652-1661.
    • (2002) N. Engl. J. Med. , vol.347 , pp. 1652-1661
    • Stanberry, L.R.1
  • 78
    • 33747886203 scopus 로고    scopus 로고
    • Identification of humoral immune responses in protein microarrays using DNA microarray data analysis techniques
    • Sundaresh S, et al. 2006. Identification of humoral immune responses in protein microarrays using DNA microarray data analysis techniques. Bioinformatics 22:1760-1766.
    • (2006) Bioinformatics , vol.22 , pp. 1760-1766
    • Sundaresh, S.1
  • 79
    • 34547852232 scopus 로고    scopus 로고
    • From protein microarrays to diagnostic antigen discovery: a study of the pathogen Francisella tularensis
    • Sundaresh S, et al. 2007. From protein microarrays to diagnostic antigen discovery: a study of the pathogen Francisella tularensis. Bioinformatics 23:i508-i518.
    • (2007) Bioinformatics , vol.23
    • Sundaresh, S.1
  • 80
    • 1842589394 scopus 로고    scopus 로고
    • Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1
    • Vollstedt S, et al. 2004. Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1. J. Virol. 78:3846-3850.
    • (2004) J. Virol. , vol.78 , pp. 3846-3850
    • Vollstedt, S.1
  • 81
    • 0030948337 scopus 로고    scopus 로고
    • Frequent genital herpes simplex virus 2 shedding in immunocompetent women Effect of acyclovir treatment
    • Wald A, et al. 1997. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J. Clin. Invest. 99:1092-1097.
    • (1997) J. Clin. Invest. , vol.99 , pp. 1092-1097
    • Wald, A.1
  • 82
    • 33747627183 scopus 로고    scopus 로고
    • Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States
    • Xu F, et al. 2006. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296:964-973.
    • (2006) JAMA , vol.296 , pp. 964-973
    • Xu, F.1
  • 83
    • 34447265951 scopus 로고    scopus 로고
    • Production of recombinant gG-1 protein of herpes simplex virus type 1 in a prokaryotic system in order to develop a typespecific enzyme-linked immunosorbent assay kit FEMS Immunol
    • Zandi K, et al. 2007. Production of recombinant gG-1 protein of herpes simplex virus type 1 in a prokaryotic system in order to develop a typespecific enzyme-linked immunosorbent assay kit. FEMS Immunol. Med. Microbiol. 50:319-323.
    • (2007) Med. Microbiol. , vol.50 , pp. 319-323
    • Zandi, K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.